Wolf, G. T., Moyer, J. S., Kaplan, M. J., Newman, J. G., Egan, J. E., Berinstein, N. L., & Whiteside, T. L. (2018). IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers. Onco Targets Ther.
Chicago Style aipamenaWolf, Gregory T., Jeffrey S. Moyer, Michael J. Kaplan, Jason G. Newman, James E. Egan, Neil L. Berinstein, and Theresa L. Whiteside. "IRX-2 Natural Cytokine Biologic for Immunotherapy in Patients With Head and Neck Cancers." Onco Targets Ther 2018.
MLA aipamenaWolf, Gregory T., et al. "IRX-2 Natural Cytokine Biologic for Immunotherapy in Patients With Head and Neck Cancers." Onco Targets Ther 2018.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.